Predictors of Radiological and Clinical Disease Reactivation in Multiple Sclerosis Patients After Cessation of Natalizumab (Tysabri)
ABSTRACT Background and Purpose: Natalizumab (NTZ) is widely used for patients with highly active relapsing–remitting multiple sclerosis (RRMS), but its discontinuation can lead to disease reactivation, significantly impacting Middle Eastern populations. This study aimed to assess the frequency of d...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Wiley
2025-09-01
|
| Серии: | Brain and Behavior |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1002/brb3.70904 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|